黑龙江完善药品生产流通使用政策

2017-11-27 董宇翔 衣晓峰 健康报

近日,黑龙江省出台《关于进一步改革完善全省药品生产流通使用政策的实施意见》,要求提高药品质量疗效,推动医药产业供给侧结构性改革。坚持监测哨点定期报告制度,建立短缺药品监测常态机制。

近日,黑龙江省出台《关于进一步改革完善全省药品生产流通使用政策的实施意见》,要求提高药品质量疗效,推动医药产业供给侧结构性改革。坚持监测哨点定期报告制度,建立短缺药品监测常态机制。

《意见》明确,医疗机构要按药品通用名称开具处方,并主动向患者提供处方。门诊患者可以自主选择在医疗机构或零售药店购药,医疗机构不得限制门诊患者凭处方到零售药店购药。具备条件的可探索将门诊药房从医疗机构剥离。

《意见》强调,要全面推行药品购销“两票制”,并利用信息化手段,加强“两票制”执行情况监督检查,建立健全跨部门、跨区域监管联动响应和协作机制,推动省公共资源交易平台、信用平台、价格平台等互联互通、数据共享,实现违法线索互联、监管标准互通、处理结果互认。推进和加强信息公开、公示,广泛接受社会监督。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1907982, encodeId=70c7190e9823e, content=<a href='/topic/show?id=2cb3103350e6' target=_blank style='color:#2F92EE;'>#黑龙江#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103350, encryptionId=2cb3103350e6, topicName=黑龙江)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Mon Mar 12 18:28:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260283, encodeId=db3c1260283ae, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Nov 29 00:28:00 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517744, encodeId=d7ff151e74495, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Wed Nov 29 00:28:00 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264894, encodeId=4bab26489427, content=谢谢分享谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160823/IMG57BBA4F88B06B5498.jpg, createdBy=29f71719637, createdName=ffffffffff, createdTime=Tue Nov 28 00:12:35 CST 2017, time=2017-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264709, encodeId=04c3264e0928, content=谢谢分享谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160823/IMG57BBA4F88B06B5498.jpg, createdBy=29f71719637, createdName=ffffffffff, createdTime=Mon Nov 27 09:41:39 CST 2017, time=2017-11-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1907982, encodeId=70c7190e9823e, content=<a href='/topic/show?id=2cb3103350e6' target=_blank style='color:#2F92EE;'>#黑龙江#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103350, encryptionId=2cb3103350e6, topicName=黑龙江)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Mon Mar 12 18:28:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260283, encodeId=db3c1260283ae, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Nov 29 00:28:00 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517744, encodeId=d7ff151e74495, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Wed Nov 29 00:28:00 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264894, encodeId=4bab26489427, content=谢谢分享谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160823/IMG57BBA4F88B06B5498.jpg, createdBy=29f71719637, createdName=ffffffffff, createdTime=Tue Nov 28 00:12:35 CST 2017, time=2017-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264709, encodeId=04c3264e0928, content=谢谢分享谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160823/IMG57BBA4F88B06B5498.jpg, createdBy=29f71719637, createdName=ffffffffff, createdTime=Mon Nov 27 09:41:39 CST 2017, time=2017-11-27, status=1, ipAttribution=)]
    2017-11-29 bioon3
  3. [GetPortalCommentsPageByObjectIdResponse(id=1907982, encodeId=70c7190e9823e, content=<a href='/topic/show?id=2cb3103350e6' target=_blank style='color:#2F92EE;'>#黑龙江#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103350, encryptionId=2cb3103350e6, topicName=黑龙江)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Mon Mar 12 18:28:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260283, encodeId=db3c1260283ae, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Nov 29 00:28:00 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517744, encodeId=d7ff151e74495, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Wed Nov 29 00:28:00 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264894, encodeId=4bab26489427, content=谢谢分享谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160823/IMG57BBA4F88B06B5498.jpg, createdBy=29f71719637, createdName=ffffffffff, createdTime=Tue Nov 28 00:12:35 CST 2017, time=2017-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264709, encodeId=04c3264e0928, content=谢谢分享谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160823/IMG57BBA4F88B06B5498.jpg, createdBy=29f71719637, createdName=ffffffffff, createdTime=Mon Nov 27 09:41:39 CST 2017, time=2017-11-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1907982, encodeId=70c7190e9823e, content=<a href='/topic/show?id=2cb3103350e6' target=_blank style='color:#2F92EE;'>#黑龙江#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103350, encryptionId=2cb3103350e6, topicName=黑龙江)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Mon Mar 12 18:28:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260283, encodeId=db3c1260283ae, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Nov 29 00:28:00 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517744, encodeId=d7ff151e74495, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Wed Nov 29 00:28:00 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264894, encodeId=4bab26489427, content=谢谢分享谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160823/IMG57BBA4F88B06B5498.jpg, createdBy=29f71719637, createdName=ffffffffff, createdTime=Tue Nov 28 00:12:35 CST 2017, time=2017-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264709, encodeId=04c3264e0928, content=谢谢分享谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160823/IMG57BBA4F88B06B5498.jpg, createdBy=29f71719637, createdName=ffffffffff, createdTime=Mon Nov 27 09:41:39 CST 2017, time=2017-11-27, status=1, ipAttribution=)]
    2017-11-28 ffffffffff

    谢谢分享谢谢分享

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1907982, encodeId=70c7190e9823e, content=<a href='/topic/show?id=2cb3103350e6' target=_blank style='color:#2F92EE;'>#黑龙江#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=103350, encryptionId=2cb3103350e6, topicName=黑龙江)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8942242, createdName=jj000001, createdTime=Mon Mar 12 18:28:00 CST 2018, time=2018-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260283, encodeId=db3c1260283ae, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Nov 29 00:28:00 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517744, encodeId=d7ff151e74495, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Wed Nov 29 00:28:00 CST 2017, time=2017-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264894, encodeId=4bab26489427, content=谢谢分享谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160823/IMG57BBA4F88B06B5498.jpg, createdBy=29f71719637, createdName=ffffffffff, createdTime=Tue Nov 28 00:12:35 CST 2017, time=2017-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=264709, encodeId=04c3264e0928, content=谢谢分享谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160823/IMG57BBA4F88B06B5498.jpg, createdBy=29f71719637, createdName=ffffffffff, createdTime=Mon Nov 27 09:41:39 CST 2017, time=2017-11-27, status=1, ipAttribution=)]
    2017-11-27 ffffffffff

    谢谢分享谢谢分享

    0

相关资讯

谈判药品进得了医保 想进医院却不简单

最近,媒体反映,经过谈判进入医保目录的药品却进不了医院,药企惊呼:砸了钱也没换来想要的。这到底是怎么回事?2017年7月由人社部组织专家进行了第二轮药品价格谈判,共有36个药品谈判成功,被纳入国家乙级医保目录。为了确保下了很大气力谈判成功的36种药品能够顺利进入医疗机构,国家卫计委、人社部就此专门下发了《关于做好36种谈判药品集中采购的通知》(国卫办药政函〔2017〕856号),各省卫计委药政管理

这16类药品不宜睡前服用

16类药品不宜睡前服用。

42药品将上市,恒瑞、豪森、科伦、齐鲁...

10月30日,国家食药监总局发布《关于药物临床试验数据自查核查注册申请情况的公告(2017年第128号)》。 ▍42药物准备生产,进口 公告表示,总局决定对新收到42个已完成临床试验申报生产或进口的药品注册申请进行临床试验数据核查。(祥见附件) 在此次的42个药物中,进口16个。恒瑞、豪森、齐鲁、科伦等国内药企都有产品申报。 ▍核查前,总局有话说 

新版艾滋病国家免费用药目录或月底出台

近日,在业界独家获得消息,已经施行超过十年的国家艾滋病免费药物目录将迎来一次重大调整。消息称国家卫计委正在讨论新一版艾滋病国家免费用药目录的修订,并且已召集数家艾滋病药品生产企业进行询价,预计有望在本月底确定最终目录。

做到这4点,让你的药品畅销基层!

据CMH数据显示,2016年,城市基层医疗市场规模高达867亿元,农村基层医疗市场规模667亿元,2016年与2015年相比,中成药口服制剂增长速度为6.9%。通过以上数据我们不难看出,基层是一个处在逢勃发展时期,又面临有待深入开发的市场。从2014年阿期利康等外企将市场视角密集下沉的到基层始,国内企业也纷纷试水基层,市场虽从数字上看着很不错,但最终表现并不尽如人意,尤以中成药为例,这是为什么

8批次疑似假药,7批次医院在用

总局发抽检通告,8批次疑似假药,7批次来自医疗机构。 ▍查封扣押31批次中药饮片11月10日,总局发布《关于31批次中药饮片不合格的通告(2017年第183号)》。通告安徽济顺中药饮片有限公司等29家企业生产的31批次中药饮片不合格。其中,20批次砂仁不合格,不合格项目包括性状和含量测定;1批次砂仁(净砂仁)不合格,不合格项目为含量测定;10批次知母不合格,不合格项目包括水分和含量测定。